{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-008932","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2025-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.663966+00:00","generated_at":"2026-05-16T13:36:40.026299+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"VolitionRx subsidiary CEO Dr. Butera to depart Jan 31, 2026; position eliminated","bullets":["Volition Veterinary CEO Dr. Salvatore Thomas Butera given termination notice, effective Jan 31, 2026.","CEO position eliminated as part of ongoing cost-realignment efforts; duties redistributed.","Dr. Butera expected to stay as part-time consultant post-termination under agreed terms.","Departure not due to any disagreement with company on operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-008932","json":"https://secwatch.observer/filing/0001477932-25-008932.json","markdown":"https://secwatch.observer/filing/0001477932-25-008932.md","text":"https://secwatch.observer/filing/0001477932-25-008932.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793225008932/0001477932-25-008932-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793225008932/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:36:40.026299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}